Wouter A. van der Linden

2.9k total citations
42 papers, 2.2k citations indexed

About

Wouter A. van der Linden is a scholar working on Molecular Biology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Wouter A. van der Linden has authored 42 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Electrical and Electronic Engineering. Recurrent topics in Wouter A. van der Linden's work include Ubiquitin and proteasome pathways (19 papers), Peptidase Inhibition and Analysis (12 papers) and Protein Degradation and Inhibitors (8 papers). Wouter A. van der Linden is often cited by papers focused on Ubiquitin and proteasome pathways (19 papers), Peptidase Inhibition and Analysis (12 papers) and Protein Degradation and Inhibitors (8 papers). Wouter A. van der Linden collaborates with scholars based in Netherlands, United States and Germany. Wouter A. van der Linden's co-authors include Herman S. Overkleeft, Alexei F. Kisselev, Matthew Bogyo, Martijn Verdoes, Bogdan I. Florea, Laura E. Sanman, Ehud Segal, Nimali P. Withana, Ian T. Foe and Lianne I. Willems and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Wouter A. van der Linden

42 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter A. van der Linden Netherlands 24 1.5k 621 436 235 234 42 2.2k
David H. Drewry United States 29 1.4k 1.0× 507 0.8× 612 1.4× 131 0.6× 242 1.0× 102 2.5k
Glen Spraggon United States 37 2.3k 1.6× 454 0.7× 390 0.9× 222 0.9× 193 0.8× 70 4.0k
Marko Fonovič Slovenia 24 1.5k 1.0× 600 1.0× 590 1.4× 146 0.6× 367 1.6× 49 2.7k
Joseph L. Kim United States 14 2.9k 2.0× 697 1.1× 230 0.5× 317 1.3× 131 0.6× 21 3.9k
Jolanta Grembecka United States 33 2.4k 1.6× 795 1.3× 613 1.4× 367 1.6× 150 0.6× 99 3.5k
Mary‐Ann Bjornsti United States 36 4.0k 2.7× 1.3k 2.1× 376 0.9× 263 1.1× 208 0.9× 79 4.8k
Sami Mahrus United States 19 1.5k 1.0× 586 0.9× 213 0.5× 146 0.6× 210 0.9× 29 2.3k
Steven H. L. Verhelst Germany 33 2.1k 1.4× 642 1.0× 1.2k 2.8× 149 0.6× 386 1.6× 111 3.3k
Paul P. Geurink Netherlands 27 2.2k 1.5× 854 1.4× 489 1.1× 403 1.7× 250 1.1× 58 2.7k
T. Krojer United Kingdom 31 2.3k 1.5× 270 0.4× 161 0.4× 142 0.6× 259 1.1× 57 3.1k

Countries citing papers authored by Wouter A. van der Linden

Since Specialization
Citations

This map shows the geographic impact of Wouter A. van der Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter A. van der Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter A. van der Linden more than expected).

Fields of papers citing papers by Wouter A. van der Linden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter A. van der Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter A. van der Linden. The network helps show where Wouter A. van der Linden may publish in the future.

Co-authorship network of co-authors of Wouter A. van der Linden

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter A. van der Linden. A scholar is included among the top collaborators of Wouter A. van der Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter A. van der Linden. Wouter A. van der Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garland, Megan, Christopher J. Schulze, Ian T. Foe, et al.. (2018). Development of an activity-based probe for acyl-protein thioesterases. PLoS ONE. 13(1). e0190255–e0190255. 15 indexed citations
2.
Hopp, Christine S., Brandy L. Bennett, Satish Mishra, et al.. (2017). Deletion of the rodent malaria ortholog for falcipain-1 highlights differences between hepatic and blood stage merozoites. PLoS Pathogens. 13(9). e1006586–e1006586. 22 indexed citations
3.
Sanman, Laura E., Wouter A. van der Linden, Martijn Verdoes, & Matthew Bogyo. (2016). Bifunctional Probes of Cathepsin Protease Activity and pH Reveal Alterations in Endolysosomal pH during Bacterial Infection. Cell chemical biology. 23(7). 793–804. 36 indexed citations
4.
Li, Hao, Anthony J. O’Donoghue, Wouter A. van der Linden, et al.. (2016). Structure- and function-based design of Plasmodium-selective proteasome inhibitors. Nature. 530(7589). 233–236. 171 indexed citations
5.
Sanman, Laura E., Qian Yu, Nicholas A. Eisele, et al.. (2016). Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. eLife. 5. e13663–e13663. 157 indexed citations
6.
Linden, Wouter A. van der, et al.. (2015). Design and Synthesis of Activity-Based Probes and Inhibitors for Bleomycin Hydrolase. Chemistry & Biology. 22(8). 995–1001. 8 indexed citations
7.
Segal, Ehud, Tyler R. Prestwood, Wouter A. van der Linden, et al.. (2015). Detection of Intestinal Cancer by Local, Topical Application of a Quenched Fluorescence Probe for Cysteine Cathepsins. Chemistry & Biology. 22(1). 148–158. 69 indexed citations
8.
Kraus, Marianne, Jürgen Bader, Paul P. Geurink, et al.. (2015). The novel  2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells. Haematologica. 100(10). 1350–1360. 41 indexed citations
9.
Edgington‐Mitchell, Laura E., Jai Rautela, Hendrika M. Duivenvoorden, et al.. (2015). Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer. Oncotarget. 6(29). 27008–27022. 39 indexed citations
10.
Li, Hao, Wouter A. van der Linden, Martijn Verdoes, et al.. (2014). Assessing Subunit Dependency of the Plasmodium Proteasome Using Small Molecule Inhibitors and Active Site Probes. ACS Chemical Biology. 9(8). 1869–1876. 42 indexed citations
11.
Li, Nan, C.J. Kuo, Hans van den Elst, et al.. (2013). Relative quantification of proteasome activity by activity-based protein profiling and LC-MS/MS. Nature Protocols. 8(6). 1155–1168. 70 indexed citations
12.
Geurink, Paul P., Wouter A. van der Linden, Anne Mirabella, et al.. (2013). Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites. Journal of Medicinal Chemistry. 56(3). 1262–1275. 84 indexed citations
13.
Kisselev, Alexei F., Wouter A. van der Linden, & Herman S. Overkleeft. (2012). Proteasome Inhibitors: An Expanding Army Attacking a Unique Target. Chemistry & Biology. 19(1). 99–115. 438 indexed citations
14.
Linden, Wouter A. van der, Lianne I. Willems, Tamer B. Shabaneh, et al.. (2011). Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones. Organic & Biomolecular Chemistry. 10(1). 181–194. 29 indexed citations
15.
Linden, Wouter A. van der. (2011). Towards subunit specific proteasome inhibitors. 1 indexed citations
16.
Screen, Michael, Sondra L. Downey-Kopyscinski, Martijn Verdoes, et al.. (2010). Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors. Journal of Biological Chemistry. 285(51). 40125–40134. 55 indexed citations
17.
Florea, Bogdan I., Martijn Verdoes, Nan Li, et al.. (2010). Activity-Based Profiling Reveals Reactivity of the Murine Thymoproteasome-Specific Subunit β5t. Chemistry & Biology. 17(8). 795–801. 70 indexed citations
18.
Verdoes, Martijn, Lianne I. Willems, Wouter A. van der Linden, et al.. (2010). A panel of subunit-selective activity-based proteasome probes. Organic & Biomolecular Chemistry. 8(12). 2719–2719. 48 indexed citations
19.
Linden, Wouter A. van der, et al.. (2010). Proteasome selectivity towards Michael acceptor containing oligopeptide-based inhibitors. Organic & Biomolecular Chemistry. 8(8). 1885–1885. 11 indexed citations
20.
Verdoes, Martijn, Bogdan I. Florea, Victoria Menéndez-Benito, et al.. (2006). A Fluorescent Broad-Spectrum Proteasome Inhibitor for Labeling Proteasomes In Vitro and In Vivo. Chemistry & Biology. 13(11). 1217–1226. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David H. Drewry Breakdown of academic impact, for papers by Glen Spraggon Breakdown of academic impact, for papers by Marko Fonovič Breakdown of academic impact, for papers by Joseph L. Kim Breakdown of academic impact, for papers by Jolanta Grembecka Breakdown of academic impact, for papers by Mary‐Ann Bjornsti Breakdown of academic impact, for papers by Sami Mahrus Breakdown of academic impact, for papers by Steven H. L. Verhelst Breakdown of academic impact, for papers by Paul P. Geurink Breakdown of academic impact, for papers by T. Krojer
Rankless by CCL
2026